ResMed
497 hedge funds and large institutions have $10.9B invested in ResMed in 2018 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 176 increasing their positions, 177 reducing their positions, and 27 closing their positions.
137% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 27
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
13% more capital invested
Capital invested by funds: $9.58B → $10.9B (+$1.27B)
7% more funds holding
Funds holding: 465 → 497 (+32)
1.18% more ownership
Funds ownership: 64.84% → 66.02% (+1.2%)
10% more call options, than puts
Call options by funds: $23M | Put options by funds: $20.9M
1% less repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 177
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$156M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$98M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$58.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$50.1M |
| 5 |
Renaissance Technologies
New York
|
+$49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$496M |
| 2 |
Millennium Management
New York
|
-$70.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$22.2M |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$19.2M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$18.8M |
RMD Hedge Fund Activity: Q3 2018 in Review
497 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2018, worth a combined $10.9B — up 13% from $9.58B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new RMD positions and 27 closed out — a net gain of 37 holders — while 176 added to existing stakes and 177 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $156M. The largest seller was Capital World Investors, cutting an estimated $496M.
- 497 institutional investors held ResMed (RMD) as of Q3 2018, up from 465 in Q2 2018.
- Funds reported $10.9B of ResMed stock for Q3 2018, up 13% quarter-over-quarter.
- 64 funds opened new ResMed positions in Q3 2018 and 27 closed out, a net change of +37 holders.
- The largest ResMed buyer in Q3 2018 was Deutsche Bank, an estimated $156M added.
- The largest ResMed seller in Q3 2018 was Capital World Investors, an estimated $496M sold.
Based on aggregated 13F filings for Q3 2018.